ICD-10 code C64.1: Malignant neoplasm of right kidney

Key Takeaways

C64.1 is the billable ICD-10-CM code for malignant neoplasm of the right kidney, excluding the renal pelvis, valid for reimbursement in FY2026

Laterality is mandatory: C64.1 (right), C64.2 (left), and C64.9 (unspecified) are not interchangeable; using the wrong code triggers claim denial

C64.1 applies to renal cell carcinoma and Wilms tumor of the right kidney but excludes renal pelvis tumors, which are coded under C65.1

Pabau’s claims management software and AI-assisted clinical documentation help urology and oncology practices capture laterality accurately and reduce billing errors

Claim denials for kidney cancer diagnoses often trace back to a single missing word: right. Under ICD-10-CM, laterality is not optional, and submitting an unspecified code when imaging clearly documents the affected side is a coding error that payers will flag. According to CMS ICD-10-CM guidelines, coders must assign the most specific code available, which means C64.1 when the right kidney is involved. This guide covers the definition, billable status, laterality rules, related codes, and documentation requirements for ICD-10 Code C64.1, with practical workflow notes for urology and oncology practices using the ICD-10-CM classification system.

Urology and oncology billing teams handle C64.1 in encounters ranging from initial diagnosis to follow-up imaging reviews and post-surgical care. Getting the code right at every stage protects revenue and keeps audit risk low.

ICD-10 Code C64.1: Definition and clinical classification

C64.1 describes a malignant neoplasm originating in the parenchyma of the right kidney, explicitly excluding any tumor arising from the renal pelvis. The renal pelvis is a separate anatomical structure with its own ICD-10-CM code (C65.1), so coders must confirm the tumor’s anatomical origin before assigning C64.1.

The code sits within the C64 parent category (Malignant neoplasm of kidney, except renal pelvis), which is itself part of the C00-C96 malignant neoplasm chapter. According to the WHO ICD-10 classification browser, C64 captures primary malignancies of kidney parenchyma under the genitourinary tract grouping C64-C68.

The most common histological type coded here is renal cell carcinoma (RCC), which originates in the proximal convoluted tubule. Wilms tumor (nephroblastoma) of the right kidney also maps to C64.1, though coders should confirm documentation supports the anatomical site before assigning the code for pediatric cases.

C64.1 code details at a glance

Billable status and when to use ICD-10 Code C64.1

C64.1 is a billable, specific ICD-10-CM code confirmed valid for FY2026 reimbursement. Coders and clinicians can use it to indicate a diagnosis on claims, encounter records, and explanation of benefits documents without needing a more detailed sub-code.

Use C64.1 when all three conditions are met:

• Imaging, biopsy, or operative report confirms a malignant neoplasm
• The tumor is documented as arising from right kidney parenchyma
• The tumor does not originate in the renal pelvis (which is C65.1)

The CDC/NCHS ICD-10-CM web tool confirms C64.1 as a current, valid code in the 2026 release. Coders working in urology or oncology should verify code status annually since CMS and NCHS co-maintain the ICD-10-CM code set and issue updates each October.

C64.1 does not capture metastatic disease on its own. When the right kidney tumor has spread, pair C64.1 with the appropriate secondary malignancy code from the C77-C79 range to reflect metastasis at the documented site. Using C64.1 alone for a patient with confirmed metastases understates the clinical picture and can trigger payer queries.

Laterality in ICD-10 Code C64.1: right vs left vs unspecified

Laterality is the most common source of coding errors in kidney cancer billing. ICD-10-CM split the old ICD-9-CM code 189.0 into three distinct codes precisely because laterality matters for treatment planning, surgical documentation, and payer adjudication.

C64.9 is not a safe default. ICD-10-CM guidelines from AAPC Codify require the most specific code available. If the operative note, CT report, or pathology summary documents “right kidney,” the coder must assign C64.1, not C64.9. Using the unspecified code when laterality is documented is a coding error that can attract post-payment audits.

Practices using laterality-specific ICD-10 codes across multiple conditions benefit from EHR templates that surface laterality fields at documentation time, reducing the risk of a provider leaving the field blank.

Related codes: C64.1 and the C64 family

Understanding the surrounding code structure helps coders avoid crossover errors and choose the right code quickly during high-volume encounters.

• C64.1 – Malignant neoplasm of right kidney, except renal pelvis (the focus of this guide)
• C64.2 – Malignant neoplasm of left kidney, except renal pelvis
• C64.9 – Malignant neoplasm of unspecified kidney, except renal pelvis
• C65.1 – Malignant neoplasm of right renal pelvis (use when the tumor arises in the renal pelvis, not the parenchyma)
• C77-C79 – Secondary malignant neoplasms (use alongside C64.1 to document metastatic spread)

The renal pelvis exclusion in C64.1 is clinically important. The renal pelvis and kidney parenchyma are distinct anatomical zones with different tissue types, oncological behavior, and treatment protocols. Transitional cell carcinoma typically arises in the renal pelvis (C65.1), while clear cell renal cell carcinoma arises in the parenchyma (C64.1). Confirm histology and anatomical origin documentation before selecting between these two codes.

For ICD-9-CM crosswalk purposes: C64.1 converts approximately from ICD-9-CM 189.0 (Malignant neoplasm of kidney, except pelvis). The crosswalk is one-to-many because ICD-9-CM 189.0 did not specify laterality. Historical records coded as 189.0 cannot be assumed to represent right kidney without reviewing the original clinical documentation.

Accurate C64.1 coding depends on the documentation chain linking the clinical encounter to the specific diagnosis. A claim submitted with C64.1 should be supportable by at least one of the following in the medical record:

• Imaging report explicitly stating “right kidney mass” or “right renal lesion” with radiological characteristics consistent with malignancy
• Pathology report confirming malignant histology from right kidney tissue
• Operative note documenting right nephrectomy or right renal biopsy with confirmed malignant findings
• Clinician diagnosis statement in the assessment section of a SOAP note or encounter summary, specifying right kidney malignancy

Vague documentation such as “renal mass” without laterality, or “kidney cancer” without specifying right or left, requires a provider query before coding proceeds. Assigning C64.1 based on clinical inference rather than explicit documentation is an audit risk under ICD-10-CM documentation standards.

Practices that deploy digital intake forms with laterality-specific fields can reduce documentation gaps at the point of care. When the intake or encounter form prompts the clinician to select right/left/bilateral for a kidney finding, the downstream coding team receives a complete record rather than having to query.

SOAP note example for C64.1

Subjective: 58-year-old male presents for follow-up of right flank pain and haematuria identified on prior workup.

Objective: CT urogram performed 14 days prior shows a 4.2 cm heterogeneously enhancing mass in the right kidney, upper pole. No contralateral involvement. No lymphadenopathy identified.

Assessment: Malignant neoplasm of the right kidney, consistent with renal cell carcinoma. No evidence of metastatic disease on current imaging.

Plan: Refer to urology for surgical evaluation. Repeat staging CT in 4 weeks. Code assigned: C64.1.

This note supports C64.1 because it explicitly names the right kidney, describes a malignant mass in the parenchyma (not the renal pelvis), and documents no metastatic disease (removing the need for a C77-C79 secondary code in this encounter).

Reduce coding errors and claim denials

Pabau helps urology and oncology practices document laterality accurately, manage claims efficiently, and keep patient records audit-ready. See how it works for your team.

Book a demo

Coding guidelines and common errors with C64.1

The ICD-10-CM Official Guidelines for Coding and Reporting, maintained by NCHS and CMS, include specific direction relevant to kidney cancer coding. Several common errors recur in urology and oncology billing workflows.

Principal vs. secondary diagnosis sequencing

When the primary reason for the encounter is treatment of the kidney malignancy, C64.1 is the principal diagnosis. When the encounter addresses a complication or associated condition (such as haematuria or post-surgical follow-up), the presenting symptom or complication may be sequenced first with C64.1 coded as an additional diagnosis, depending on payer rules and encounter context.

Combining C64.1 with metastasis codes

C64.1 does not capture spread beyond the right kidney. If the patient has documented regional lymph node involvement, assign a secondary malignant neoplasm code from C77 alongside C64.1. For distant organ metastases, use the appropriate C79.x code. Omitting secondary codes when metastases are documented is a clinical accuracy problem and a billing compliance risk.

Wilms tumor and C64.1

Wilms tumor (nephroblastoma) of the right kidney maps to C64.1 when the tumor arises in the renal parenchyma. Some pediatric coding scenarios may prompt queries about alternative codes, but multiple clinical coding references confirm C64.1 as the appropriate code for right-kidney Wilms tumor when documentation supports parenchymal origin. Confirm documentation specifics and consult payer guidelines for pediatric oncology cases if uncertain.

Reviewing the ICD List diagnostic code database alongside clinical notes helps coders verify that the selected code matches the documented diagnosis before claim submission.

Getting C64.1 into the claim cleanly requires a documentation workflow that captures laterality at each stage of the patient journey, from first imaging result through surgical follow-up. Practices that rely on free-text notes alone tend to produce more unspecified codes because laterality gets buried in narrative rather than surfacing in a structured field.

A patient record system that supports structured diagnosis fields allows the treating clinician to select “right kidney” explicitly, rather than typing “kidney cancer” and leaving the coder to infer laterality. That structured entry flows directly to the billing module, pre-populating C64.1 rather than C64.9.

Practices managing multi-stage oncology workflows benefit from combining structured records with claims management software that flags missing laterality fields before a claim leaves the system. Catching an unspecified code at pre-submission review costs seconds; catching a denial and appealing it costs staff hours.

For practices handling high documentation volumes across urology and oncology patients, AI-assisted clinical documentation can transcribe encounter details into structured SOAP notes, reducing the manual entry burden while preserving the specificity payers require. Documentation accuracy across a dermatology and oncology EMR software environment ultimately determines whether C64.1 or C64.9 lands on the claim.

Maintaining HIPAA-compliant clinic software is a baseline requirement for any practice handling oncology diagnoses, given the sensitivity of cancer-related records. The combination of structured documentation workflows, laterality-aware templates, and a practice management platform with integrated billing reduces the distance between the clinical record and a correctly coded claim. Using structured medical forms across urology encounters ensures laterality fields are never omitted at intake.

Conclusion

Laterality errors in kidney cancer coding are preventable with the right documentation workflow. C64.1 is specific, billable, and required whenever the right kidney parenchyma is the confirmed site of malignancy. Using C64.9 when C64.1 is supportable by the record is a compliance gap, not a safe choice.

Pabau’s compliance management tools help urology and oncology practices build structured documentation workflows that capture laterality at the point of care, reducing the audit risk that comes with unspecified codes. To see how Pabau supports oncology and urology coding accuracy, book a demo with our team.

Continue your research

Need ICD-10 coding reference for neurological diagnoses? Intraparenchymal hemorrhage ICD-10 codes covers laterality-specific neurological coding with the same level of clinical detail.

Looking for a clinical documentation workflow that captures diagnosis specificity? Digital intake forms let practices build laterality-specific fields directly into encounter and intake workflows.

Want to reduce claim denials across your oncology billing team? Claims management software from Pabau flags incomplete diagnosis fields before submission, catching unspecified codes at the pre-claim review stage.

Frequently Asked Questions